Ly96 - lymphocyte antigen 96

Predicted to enable lipopolysaccharide immune receptor activity. Predicted to be involved in positive regulation of tumor necrosis factor production; response to lipopolysaccharide; and toll-like receptor 4 signaling pathway. Predicted to act upstream of or within positive regulation of lipopolysaccharide-mediated signaling pathway and response to lipopolysaccharide. Predicted to be intrinsic component of plasma membrane. Predicted to be part of lipopolysaccharide receptor complex. Orthologous to human LY96 (lymphocyte antigen 96). [provided by Alliance of Genome Resources, Apr 2022]